Clinical Trial: Screening of Key Genes for Neuroendocrine Differentiation in Prostatic Adenocarcinoma and Study on Its Mechanism and Intervention Verification (China)

China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Screening of Key Genes for Neuroendocrine Differentiation in Prostatic Adenocarcinoma and Study on Its Mechanism and Intervention Verification'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129934

Registration Time: 2026/08/12

Type: Observational study

Primary Sponsor: Fuzhou University Affiliated Provincial Hospita

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=324893

Published by HT Digital Content Services with permission from Health Daily Digest....